20 May 2013 07:17 [Source: ICIS news]
GUANGZHOU (ICIS)--Dutch specialty chemicals firm DSM expects to generate more than $3bn in sales from China by 2015 as it expects to start up a new caprolactam (capro) plant in the country soon, the company’s CEO for Asia Kong Muheng said on Monday.
The company plans to commence production at its 200,000 tonne/year capro plant in Nanjing late this year or in early 2014, said Jeroen Crevecoeur, research and technology director at DSM.
Output from the Nanjing plant will be supplied to the domestic Chinese market, with a small portion to be exported, Jeroen said.
"We had already moved our global headquarters [for engineering plastics] to Singapore last year, which can show our confidence in [the] Asia[n] market," Crevecoeur said.
Next year, the company is planning to build an application centre for engineering plastics in India, Jeroen said.
The four-day 2013 Chinaplas 2013 in Guangzhou ends Thursday.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|
Asian Chemical Connections